This trial is terminated!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Alzheimers Disease or AD
and you are
over 55
years old
Phase
0
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

[F-18]T807 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.

Provided treatments

  • Radiation: [F18] T807
Tris trial is registered with FDA with number: NCT01733355. The sponsor of the trial is Avid Radiopharmaceuticals and it is looking for 11 volunteers for the current phase.
Official trial title:
A Phase 0, Open Label, Non-randomized, Multi-center Exploratory and Safety Study of [F-18]T807